# A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers

> **NCT02371889** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 320 (actual)

## Conditions studied

- Alcoholism
- Alcohol Use Disorder (AUD)

## Interventions

- **DRUG:** Topiramate
- **BEHAVIORAL:** Medical Management
- **DRUG:** Inactive Placebo

## Key facts

- **NCT ID:** NCT02371889
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-18
- **Primary completion:** 2020-02
- **Final completion:** 2020-02
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2022-01-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02371889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02371889, "A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02371889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*